Groupe SYNERLAB (CDMO) generate a turnover of 130 million euros in 2018 and operate 6 factories in Europe. SYNERLAB currently employ over 1 000  people and are dedicated to pharmaceutical development and manufacturing.Groupe SYNERLAB  offer  solutions for analytical and galenical development, manufacturing and packaging of medicinal products for human, veterinary use, medical devices and food supplements in various dosage forms, especially for solid and liquid oral form, non-injectable sterile liquids and custom freeze-drying. We are one of the leading manufacturers in the markets for pharmaceutical and veterinary products, food supplements, diagnostics and medical devices. As a CDMO specialising in multi-form products, we manufacture all kinds of batches: for clinical trials, pilot batches and industrial batches.Our expertise, combining high demands and safety, is recognised among the leading international laboratories. The combination of our know-how, equipment and production areas provides our customers with an appropriate, flexible response to all their requirements. Our main aim is clearly to provide our customers with relevant responses. Contact : [email protected]

Sales Markets

Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America

Contact information




View All Contact Info

Top Products

Alu-Alu Strip


Categories affiliated with SYNERLAB